2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
The three most prominent themes in stock investing this year have been artificial intelligence (AI), weight-loss care, and profitability. Companies with strong profitability and/or ties to AI and obesity have, on balance, outperformed the broader markets in 2023. Not all of these high-flying equities are ripe for profit-taking, however. A handful of these top-performing stocks still have ample room to run over the long term.
Healthcare stocks Regeneron Pharmaceuticals(NASDAQ: REGN) and Vertex Pharmaceuticals (NASDAQ: VRTX) are prime examples. Even though both stocks bumped up against their 52-week high in recent trading, each company still screens as a compelling buy-and-hold for investors with an extended horizon. Read on to find out more about these two innovation-oriented healthcare stocks.
Image Source: Getty Images.
Source Fool.com
Regeneron Pharmaceuticals Inc. Aktie
Regeneron Pharmaceuticals Inc. ist ein klarer Community-Favorit mit mehr Buy- als Sell-Einschätzungen.
Ein positives Kurspotenzial für Regeneron Pharmaceuticals Inc. ist gegeben, mit einem Kursziel von 1040 € über dem aktuellen Kurs von 997.4 €.
